Could CRISPR Therapeutics Stock Help You Become a Millionaire?
22/1 11:05
Right now marks an exciting moment for CRISPR Therapeutics (NASDAQ: CRSP) and its investors. The biotech company has reached three milestones in just a couple of months. First, back in November, the U.K. authorized Casgevy for sickle cell disease and beta thalassemia, the world's...